Molecular Epidemiology of Non-Hodgkin Lymphoma Survival
Contact: James R. Cerhan, M.D., Ph.D.
| Number of Enrolled Cancer Patients/Survivors: | Ongoing (currently >4500) |
|---|---|
| Years of Diagnoses of Enrolled Cancer Patients/Survivors: | 2002-current |
| Approximate Years of Follow-up: | Median follow-up on living patients is 3 years (max.: 9 years) |
| Cancer Sites Represented: | Non-Hodgkin Lymphoma (including CLL) |
| Biological Specimens Collected: |
Blood/Blood Fraction Buccal Cells Germline DNA Formalin Fixed Tumor Tissue Fresh Frozen Tumor Tissue |
| Treatment Outcome Measures: |
Physician/Medical Record Reported
|
| Co-morbidities at Study Entry: |
Diabetes Heart Disease Pulmonary Disease Other |
| Lifestyle Factors: |
Smoking Alcohol Use Diet Physical Activity Body Mass Index Weight Loss/Control Other |
| Treatment Data: |
Surgery Radiation Chemotherapy Hormonal Therapy Bone Marrow/Stem Cell Transplant Other |
| Treatment Data Assessed By: |
Electronic Record Chart Abstraction Patient Reported Questionnaire |
| Is the study open to collaboration? | Yes |